Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

…, JP Reilly, AR Weisman, CAG Ittner, O Kuthuru… - Science, 2020 - science.org
INTRODUCTION Many patients with coronavirus disease 2019 (COVID-19), caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, present with severe …

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

…, M McLaughlin, JC Williams, S Adamski, O Kuthuru… - Science, 2021 - science.org
INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA
vaccines are highly effective at preventing infection and especially severe disease. However, …

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination

…, MM Painter, D Mathew, A Pattekar, O Kuthuru… - Science …, 2021 - science.org
mRNA vaccines for SARS-CoV-2 have been authorized for emergency use. Despite their
efficacy in clinical trials, data on mRNA vaccine–induced immune responses are mostly limited …

[PDF][PDF] Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination

…, RR Goel, SA Apostolidis, A Pattekar, O Kuthuru… - Immunity, 2021 - cell.com
SARS-CoV-2 mRNA vaccines have shown remarkable clinical efficacy, but questions
remain about the nature and kinetics of T cell priming. We performed longitudinal antigen-specific …

Comprehensive mapping of immune perturbations associated with severe COVID-19

…, D Mathew, AE Baxter, LA Vella, O Kuthuru… - Science …, 2020 - science.org
Although critical illness has been associated with SARS-CoV-2–induced hyperinflammation,
the immune correlates of severe COVID-19 remain unclear. Here, we comprehensively …

[PDF][PDF] Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

…, JE Wu, C Alanio, K D'Andrea, O Kuthuru… - Cell, 2021 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread within
the human population. Although SARS-CoV-2 is a novel coronavirus, most humans had been …

[PDF][PDF] Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine

…, M McLaughlin, JC Williams, S Adamski, O Kuthuru… - Cell, 2022 - cell.com
We examined antibody and memory B cell responses longitudinally for ∼9–10 months after
primary 2-dose SARS-CoV-2 mRNA vaccination and 3 months after a 3rd dose. Antibody …

Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19

…, SA Apostolidis, AC Huang, D Mathew, O Kuthuru… - Science …, 2021 - science.org
Pediatric coronavirus disease 2019 (COVID-19) after SARS-CoV-2 infection is associated
with fewer hospitalizations and often milder disease than in adults. A subset of children, …

Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection

…, LE Felley, M McLaughlin, J Weaver, O Kuthuru… - Nature …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of vaccinated
individuals is increasingly common but rarely results in severe disease, likely due to the …

SARS-CoV-2 seroprevalence among parturient women in Philadelphia

…, J Kim, N Han, A Pattekar, J Dougherty, O Kuthuru… - Science …, 2020 - science.org
Limited data are available for pregnant women affected by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). Serological tests are critically important for determining …